全球藥物濫用檢測市場規模、佔有率、趨勢和成長分析報告（2026-2034年）

預計藥物濫用檢測市場將從 2025 年的 16.2 億美元成長到 2034 年的 26 億美元，2026 年至 2034 年的複合年成長率為 5.38%。

由於全球藥物濫用案件的增加和監管政策的日益嚴格，全球藥物濫用檢測市場正在顯著擴張。各國政府和組織正在強制要求職場進行藥物檢測，以確保安全和合規性。鴉片類藥物成癮的蔓延以及人們對藥物濫用的認知不斷提高，都推動了醫療保健、執法和企業等領域的市場穩步成長。

關鍵成長要素包括快速檢測套組、免疫檢測分析儀和實驗室確認方法的技術進步。就地檢驗設備的普及提高了效率並縮短了出結果的時間。此外，路邊毒品檢測計畫的擴展和毒理學實驗室投資的增加，正在推動已開發國家和開發中國家的市場成長。

隨著數位化整合和攜帶式偵測設備日趨成熟且價格更加親民，市場前景依然強勁。復健設施的擴建和更嚴格的藥品監管將進一步刺激需求。新興市場由於醫療基礎設施的改善和宣傳宣傳活動的發展，預計將迎來巨大的發展機會。總體而言，持續的政策支持和技術創新有望支撐市場的長期成長。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球藥物濫用檢測市場：依藥物類型分類

• 市場分析、洞察與預測
• 精神興奮劑
• 藥品
• 大麻素
• 鎮靜劑
• 其他

第5章 全球藥物濫用檢測市場：依技術類型分類

• 市場分析、洞察與預測
• 免疫檢測
• 層析法
• 快速檢測

第6章 全球藥物濫用檢測市場：依最終用戶分類

• 市場分析、洞察與預測
• 醫院
• 診斷檢測實驗室
• 法醫科學研究所
• 其他

第7章 全球藥物濫用檢測市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Abbott Laboratories（Alere Inc.）
  • F. Hoffmann La-Roche Ltd
  • Siemens AG（Siemens Healthineers）
  • Thermo Fisher Scientific Inc
  • Drgerwerk AG Co KGaA
  • Chromsystems Instruments & Chemicals GmbH
  • AccuBioTech Co. Ltd
  • Screen Italia Srl
  • Paramedical SRL
  • MP Biomedicals

The Drugs of Abuse Testing Market size is expected to reach USD 2.60 Billion in 2034 from USD 1.62 Billion (2025) growing at a CAGR of 5.38% during 2026-2034.

The Global Drugs of Abuse Testing Market is expanding significantly due to increasing substance abuse cases and strict regulatory policies worldwide. Governments and organizations are implementing mandatory workplace drug testing to ensure safety and compliance. The growing prevalence of opioid addiction and rising awareness regarding drug misuse are contributing to the market's steady growth across healthcare, law enforcement, and corporate sectors.

Major growth drivers include technological advancements in rapid testing kits, immunoassay analyzers, and laboratory-based confirmation methods. Increasing adoption of point-of-care testing devices has improved efficiency and reduced turnaround time. Additionally, expanding roadside drug testing programs and rising investments in toxicology laboratories are fueling market expansion in developed and developing regions alike.

Future prospects remain strong as digital integration and portable testing devices become more advanced and affordable. The expansion of rehabilitation centers and stricter anti-drug regulations will further boost demand. Emerging markets are expected to present significant opportunities due to improving healthcare infrastructure and awareness campaigns. Overall, consistent policy support and technological innovation will sustain long-term market growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Drug Type

• Psychostimulants
• Narcotics
• Cannabinoids
• Sedatives
• Others

By Technique Type

• Immunoassay
• Chromatography
• Rapid Testing

By End User

• Hospitals
• Diagnostics Laboratories
• Forensic Laboratories
• Others

COMPANIES PROFILED

• Abbott Laboratories Alere Inc, F Hoffmann LaRoche Ltd, Siemens AG Siemens Healthineers, Thermo Fisher Scientific Inc, Drgerwerk AG Co KGaA, Chromsystems Instruments Chemicals GmbH, AccuBioTech Co Ltd, Screen Italia Srl, Paramedical srl, MP Biomedicals
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY DRUG TYPE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Drug Type
• 4.2. Psychostimulants Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Narcotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Cannabinoids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Sedatives Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY TECHNIQUE TYPE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Technique Type
• 5.2. Immunoassay Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Chromatography Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Rapid Testing Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY END USER 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End User
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Diagnostics Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Forensic Laboratories Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DRUGS OF ABUSE TESTING MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Drug Type
  • 7.2.2 By Technique Type
  • 7.2.3 By End User
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Drug Type
  • 7.3.2 By Technique Type
  • 7.3.3 By End User
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Drug Type
  • 7.4.2 By Technique Type
  • 7.4.3 By End User
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Drug Type
  • 7.5.2 By Technique Type
  • 7.5.3 By End User
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Drug Type
  • 7.6.2 By Technique Type
  • 7.6.3 By End User
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DRUGS OF ABUSE TESTING INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Abbott Laboratories (Alere Inc.)
  • 9.2.2 F. Hoffmann La-Roche Ltd
  • 9.2.3 Siemens AG (Siemens Healthineers)
  • 9.2.4 Thermo Fisher Scientific Inc
  • 9.2.5 Drgerwerk AG Co KGaA
  • 9.2.6 Chromsystems Instruments & Chemicals GmbH
  • 9.2.7 AccuBioTech Co. Ltd
  • 9.2.8 Screen Italia Srl
  • 9.2.9 Paramedical S.R.L
  • 9.2.10 MP Biomedicals